Cadrenal Therapeutics, Inc. (CVKD) › Shares OutstandingCadrenal Therapeutics, Inc. (CVKD) — Shares OutstandingAnnual figures by period end, from SEC filings.2022-12-31: 8.19M2023-12-31: 868.2K2024-12-31: 1.78M2025-12-31: 2.34M2.34M2022-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-312.34M+31.2%2026-03-31Balance as of period end2024-12-311.78M+105.3%2026-03-31Balance as of period end2023-12-31868.2K-89.4%2025-03-13Balance as of period end2022-12-318.19M—2024-03-11Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)